Circulating irisin in healthy, young individuals: Day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 9, 2014, Pages 3247-3255

  Anastasilakis, Athanasios D ^a   Polyzos, Stergios A ^b   Saridakis, Zacharias G ^c   Kynigopoulos, Georgios ^c   Skouvaklidou, Elpida C ^c   Molyvas, Dimitrios ^c   Vasiloglou, Maria F ^d   Apostolou, Aggeliki ^d   Karagiozoglou Lampoudi, Thomai ^d   Siopi, Aikaterina ^b   Mougios, Vassilis ^b   Chatzistavridis, Panagiotis ^b   Panagiotou, Grigorios ^e   Filippaios, Andreas ^e   Delaroudis, Sideris ^a   Mantzoros, Christos S ^e  

^a 424 General Army Hospital   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Hellenic Military School of Medicine   (Greece)

^d ALEXANDER TECHNOLOGICAL EDUCATIONAL INSTITUTE OF THESSALONIKI   (Greece)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CREATINE KINASE; CYTOKINE; GLUCOSE; HYDROCORTISONE; IRISIN; LEPTIN; UNCLASSIFIED DRUG; URIC ACID; ADIPOQ PROTEIN, HUMAN; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CALORIC INTAKE; CIRCADIAN RHYTHM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIETARY INTAKE; EATING HABIT; ENERGY EXPENDITURE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HIP CIRCUMFERENCE; HOMEOSTATIC MODEL OF ASSESSMENT INSULIN RESISTANCE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; INTERVENTION STUDY; LEAN BODY WEIGHT; MALE; MEDICAL STUDENT; METABOLIC PARAMETERS; NORMAL HUMAN; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SEX DIFFERENCE; TOTAL BODY WATER; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; EATING; EXERCISE; FEEDING BEHAVIOR; MOTOR ACTIVITY; PHYSIOLOGY; QUESTIONNAIRE; YOUNG ADULT;

ADIPONECTIN; BODY COMPOSITION; BODY MASS INDEX; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; EATING; EXERCISE; FEMALE; FIBRONECTINS; FOOD HABITS; HEALTHY VOLUNTEERS; HUMANS; LEPTIN; MALE; MOTOR ACTIVITY; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEX FACTORS; YOUNG ADULT;

EID: 84907212718     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1367     Document Type: Article

References (29)

1. Raschke S, Eckel J. Adipo-myokines: two sides of the same coinmediators of inflammation and mediators of exercise. Mediators Inflamm. 2013; 320724.
2. Roca-Rivada A, Castelao C, Senin LL, et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One. 2013; 8: e60563.
3. Boström P, Wu J, Jedrychowski MP, et al. A PGC1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481: 463-468.
4. Staiger H, Böhm A, Scheler M, et al. Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity. PLoS One. 2013; 8: e61903.
5. Liu JJ, Wong MD, Toy WC, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications. 2013; 27: 365-369.
6. Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013; 98: E769-E778.
7. Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012; 61: 1725-1738.
8. Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS. Irisin in patients with nonalcoholic fatty liver disease. Metabolism. 2014; 63: 207-217.
9. Park KH, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013; 98: 4899-4907.
10. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides. 2013; 39: 125-130.
11. Sanchis-Gomar F, Perez-Quilis C. Irisinemia: a novel concept to coin in clinical medicine? Ann Nutr Metab. 2013; 63: 60-61.
12. Polyzos SA, Kountouras J, Shields K, Mantzoros CS. Irisin: a renaissance in metabolism? Metabolism. 2013; 62: 1037-1044.
13. Boström PA, Fernández-Real JM, Mantzoros C. Irisin in humans: recent advances and questions for future research. Metabolism. 2014; 63: 178-180.
14. Bountziouka V, Bathrellou E, Giotopoulou A, et al. Development, repeatability and validity regarding energy and macronutrient intake of a semi-quantitative food frequency questionnaire: methodological considerations. Nutr Metab Cardiovasc Dis. 2012; 22: 659-667.
15. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003; 348: 2599-2608.
16. Kurdiova T, Balaz M, Vician M, et al. Are skeletal muscle, adipose tissue Fndc5 gene expression and irisin release affected by obesity, diabetes and exercise? In vivo, in vitro studies. J Physiol. 2014; 592: 1091-1107.
17. Al-Daghri NM, Alkharfy KM, Rahman S, et al. Irisin as a predictor of glucose metabolism in children: Sexually dimorphic effects. Eur J Clin Invest. 2014; 44: 119-124.
18. Crujeiras AB, Pardo M, Arturo RR, et al. Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women. Am J Hum Biol. 2014; 26: 198-207.
19. Zhang HJ, Zhang XF, Ma ZM, et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol. 2013; 59: 557-562.
20. Norheim F, Langleite TM, Hjorth M, et al. The effects of acute and chronic exercise on PGC-1, irisin and browning of subcutaneous adipose tissue in human. FEBS J. 2014; 281: 739-749.
21. Kraemer RR, Shockett P, Webb ND, Shah U, Castracane VD. A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women. Horm Metab Res. 2014; 46: 150-154.
22. Fain JN, Company JM, Booth FW, et al. Exercise training does not increase muscle FNDC5 protein or mRNA expression in pigs. Metabolism. 2013; 62: 1503-1511.
23. Hecksteden A, Wegmann M, Steffen A, et al. Irisin and exercise training in humans-results from a randomized controlled training trial. BMC Med. 2013; 11: 235.
24. Besse-Patin A, Montastier E, Vinel C, et al. Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine. Int J Obes (Lond). 2014; 38: 707-713.
25. Pekkala S, Wiklund PK, Hulmi JJ, et al. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J Physiol. 2013; 591: 5393-5400.
26. Lee P, Brychta RJ, Linderman J, Smith S, Chen KY, Celi FS. Mild cold exposure modulates fibroblast growth factor 21 (FGF21) diurnal rhythm in humans: relationship between FGF21 levels, lipolysis, and cold-induced thermogenesis. J Clin Endocrinol Metab. 2013; 98: E98-E102.
27. Gutenbrunner C. Circadian variations of the serum creatine kinase level-A masking effect? Chronobiol Int. 2000; 17: 583-590.
28. Park KH, Zaichenko L, Peter P, Davis CR, Crowell JA, Mantzoros CS. Diet quality is associated with circulating C-reactive protein but not irisin levels in humans. Metabolism. 2014; 63: 233-241.
29. Roberts MD, Bayless DS, Company JM, et al. Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats. Metabolism. 2013; 62: 1052-1056.